Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research

Mass spectrometry‐based metabolomics has become increasingly popular in molecular medicine. High‐definition mass spectrometry (MS), coupled with pattern recognition methods, have been carried out to obtain comprehensive metabolite profiling and metabolic pathway of large biological datasets. This se...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 30; no. 1; pp. 7 - 12
Main Authors Zhang, Aihua, Sun, Hui, Yan, Guangli, Wang, Ping, Wang, Xijun
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.01.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mass spectrometry‐based metabolomics has become increasingly popular in molecular medicine. High‐definition mass spectrometry (MS), coupled with pattern recognition methods, have been carried out to obtain comprehensive metabolite profiling and metabolic pathway of large biological datasets. This sets the scene for a new and powerful diagnostic approach. Analysis of the key metabolites in body fluids has become an important part of improving disease diagnosis. With technological advances in analytical techniques, the ability to measure low‐molecular‐weight metabolites in bio‐samples provides a powerful platform for identifying metabolites that are uniquely correlated with a specific human disease. MS‐based metabolomics can lead to enhanced understanding of disease mechanisms and to new diagnostic markers and has a strong potential to contribute to improving early diagnosis of diseases. This review will highlight the importance and benefit with certain characteristic examples of MS‐metabolomics for identifying metabolic pathways and metabolites that accurately screen for potential diagnostic biomarkers of diseases. Copyright © 2015 John Wiley & Sons, Ltd.
Bibliography:istex:FA52BC620DE9E68026CCDA529E29446998493AF9
Key Program of Natural Science Foundation of State - No. 81430093; No. 81173500; No. 81373930; No. 81302905; No. 81202639
ArticleID:BMC3453
Key Technology Research and Development Program of the Ministry of Science and Technology of China - No. 2011BAI03B03; No. 2011BAI03B06; No. 2011BAI03B08
Foundation of Heilongjiang University of Chinese Medicine - No. 201209
ark:/67375/WNG-C1F3DMKH-P
National Key Subject of Drug Innovation - No. 2009ZX09502-005
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
ObjectType-Review-4
content type line 23
ISSN:0269-3879
1099-0801
1099-0801
DOI:10.1002/bmc.3453